Zobrazeno 1 - 10
of 145
pro vyhledávání: '"R. Terg"'
Publikováno v:
The International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences, Vol XL-7/W3, Pp 1221-1226 (2015)
Citizen science is a promising way to increase temporal and spatial coverages of in-situ data, and to aid in data processing and analysis. In this paper, we present how citizen science can be used together with Earth observation, and demonstrate its
Externí odkaz:
https://doaj.org/article/86c26528610a4f5f80955a070c0ef949
Autor:
Marcelo Silva, Fernando Barreyro, Luis Colombato, Eduardo Fassio, Paola Casciato, Carla Niveyro, Manuel Mendizabal, Cecilia Garbe, Mariano Cartier, R. Terg, M. Marino, Adrián Gadano, Pablo A Salgado, Javier Benavides, Teodoro E. Stieben, Daniel Berbara
Publikováno v:
Journal of Hepatology. 62:1056-1060
BACKGROUND & AIM Retrospective studies show an association between proton pump inhibitor (PPI) therapy and spontaneous bacterial peritonitis (SBP). We investigate the relationship between PPI and SBP in decompensated cirrhotic patients in a large nat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf77eaa1f2fcc0a49286697cd113a6eb
https://doi.org/10.1016/j.jhep.2014.11.036
https://doi.org/10.1016/j.jhep.2014.11.036
Autor:
Louis Griffel, Carlos Brandao Mello, Jordi Bruix, Pierre Bedossa, Thierry Poynard, Claus Niederau, Janice K. Albrecht, R. Terg, Rainer Guenther, Eugene R. Schiff, J.L. Poo, Margaret Burroughs, Kelly W. Burak, Navdeep Boparai, Elizabeth J. Heathcote, Massimo Colombo, Thomas Berg, Clifford A. Brass
Publikováno v:
Gastroenterology. 140:1990-1999
Background & Aims Several studies have reported that low doses of interferon can delay the development of hepatocellular carcinoma (HCC) and progression of chronic hepatitis C. We investigated the incidence of clinical events among participants of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79179c5f94762d53ad7dbc280fd9ab9c
https://doi.org/10.1053/j.gastro.2011.03.010
https://doi.org/10.1053/j.gastro.2011.03.010
Autor:
Steven L. Flamm, Massimo Colombo, Ricardo Moreno-Otero, Louis Griffel, Marcelo Silva, E. Jenny Heathcote, Eugene R. Schiff, Moisés Diago, Navdeep Boparai, Janice K. Albrecht, Fernando L. Gonçales, Thomas Berg, Clifford A. Brass, Warren N. Schmidt, R. Terg, Jordi Bruix, Thierry Poynard, Mona Munteanu, Flair José Carrilho, Antonio Craxì, Thomas J. McGarrity, Margaret Burroughs
Publikováno v:
Journal of Hepatology. 54:227-235
Background & Aims EPIC-3 is a prospective, international study that has demonstrated the efficacy of PEG-IFN alfa-2b plus weight-based ribavirin in patients with chronic hepatitis C and significant fibrosis who previously failed any interferon–alfa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97bca29611371b2e50bc39b81db499d4
https://doi.org/10.1016/j.jhep.2010.06.038
https://doi.org/10.1016/j.jhep.2010.06.038
Autor:
Alberto Muñoz, R. Terg, Romina Lucero, Mariano Cartier, Gustavo Romero, Raquel Abecasis, Diana Levi, Carlos Miguez
Publikováno v:
Alimentary Pharmacology & Therapeutics. 32:43-48
Aliment Pharmacol Ther 2010; 32: 43–48 Summary Background Cirrhotic patients with spontaneous bacterial peritonitis (SBP) have elevated rates of renal impairment and mortality. It has been shown that cefotaxime plus albumin infusion decrease renal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76dae726cb04c8161d0d24528c8775b7
https://doi.org/10.1111/j.1365-2036.2010.04309.x
https://doi.org/10.1111/j.1365-2036.2010.04309.x
Autor:
Adrián Gadano, Carlos Miguez, Gonzalo Terg, R. Terg, Romina Lucero, Alberto Muñoz, Mariano Cartier, Diana Levi, Paola Casciato, Raquel Abecasis, Gustavo Romero
Publikováno v:
Liver International. 29:415-419
Background: Patients with spontaneous bacterial peritonitis (SBP) are at a high risk for renal failure and death despite successful treatment of infection. Intravenous (IV) albumin administration combined with antibiotic treatment has been shown to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21186b1ff4ceacfbb150acfaf5a3c203
https://doi.org/10.1111/j.1478-3231.2008.01877.x
https://doi.org/10.1111/j.1478-3231.2008.01877.x
Autor:
N. Dominguez, A. Suarez, R. Terg, Julio Argonz, E. Fassio, David Kravetz, C. Vulcano, Alberto Muñoz, P. Salgado, Gustavo Romero, A. Bosco
Publikováno v:
Alimentary Pharmacology & Therapeutics. 24:601-611
SUMMARY Background After variceal bleeding, cirrhotic patients should receive secondary prophylaxis. Aim To compare nadolol plus 5-isosorbide mononitrate (5-ISMN) with endoscopic band ligation. The end points were rebleeding, treatment failure and de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c98d81be7a384e31685656716fa7a51
https://doi.org/10.1111/j.1365-2036.2006.03007.x
https://doi.org/10.1111/j.1365-2036.2006.03007.x
Autor:
R. Terg
Publikováno v:
Hepatology. 57:411-413
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d325e8c74231104aba240b17384e64d2
https://doi.org/10.1002/hep.26098
https://doi.org/10.1002/hep.26098
Autor:
Eric Hughes, Claudia Martorell, Jean-Pierre Bronowicki, Fernando Bessone, David Cohen, Paul J. Thuluvath, Timothy Eley, Ziad Younes, Stanislas Pol, Dennis Hernandez, Patricia Mendez, Fiona McPhee, Bing He, Fei Yu, Vlad Ratziu, Adrián Gadano, R. Terg
Publikováno v:
Journal of Hepatology
Journal of Hepatology, Elsevier, 2014, 61 (6), pp.1220-1227. ⟨10.1016/j.jhep.2014.07.011⟩
Journal of Hepatology, Elsevier, 2014, 61 (6), pp.1220-1227. ⟨10.1016/j.jhep.2014.07.011⟩
Background & Aims Asunaprevir is a selective HCV NS3 protease inhibitor, active against genotypes 1, 4, 5, and 6 in vitro . We evaluated asunaprevir plus peginterferon alfa-2a/ribavirin (PegIFNα/RBV) for genotype 1 and 4 chronic HCV. Methods In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b08236cfa6528716c885bc93fc03b76
https://pubmed.ncbi.nlm.nih.gov/25038486
https://pubmed.ncbi.nlm.nih.gov/25038486
Publikováno v:
Tissue Antigens. 30:238-240
Fifty-one patients with chronic active hepatitis were typed for their HLA- A, B, C, and DR antigens. We observed a significant increase in the antigen frequency of HLA B35 in patients compared with controls.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e477f8db0456a7dbdc226f58ce650a
https://doi.org/10.1111/j.1399-0039.1987.tb01628.x
https://doi.org/10.1111/j.1399-0039.1987.tb01628.x